On November 21, 2017 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported that it will present at the 29th Annual Piper Jaffray Healthcare Conference at 12:00 p.m. ET on Tuesday, Nov. 28, 2017, in New York City (Press release, Neurocrine Biosciences, NOV 21, 2017, View Source;p=RssLanding&cat=news&id=2318193 [SID1234522213]). Timothy P. Coughlin, Vice President Finance of Neurocrine Biosciences, will present at the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live presentation will be webcast and may be accessed on the Company’s website at View Source A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

On November 21, 2017 Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of disease-driving genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the 29th Annual Piper Jaffray Healthcare Conference. Details are as follows (Press release, Syros Pharmaceuticals, NOV 21, 2017, View Source [SID1234522201]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

29th Annual Piper Jaffray Healthcare Conference
Date: Tuesday, November 28
Presentation Time: 2:30 p.m. ET
Location: Lotte New York Palace Hotel, 455 Madison Ave, New York, NY

A live webcast of the fireside chat will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay will be available for approximately 30 days following the fireside chat.

On November 21, 2017 Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, reported that Bill Enright, president and chief executive officer of Altimmune, will present a corporate overview at the 29th Annual Piper Jaffray Conference, taking place November 28-29, 2017 in New York, NY (Press release, Altimmune, NOV 21, 2017, View Source [SID1234522185]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:
Date: November 28, 2017
Time: 2:00pm Eastern Standard Time
Location: Lotte New York Palace Hotel; New York, NY

ImmunoCellular Therapeutics has filed a 10-Q – Quarterly report [Sections 13 or 15(d)] with the U.S. Securities and Exchange Commission (Filing, 10-Q, ImmunoCellular Therapeutics, 2017, NOV 21, 2017, View Source [SID1234522204]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On November 21, 2017 Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, reported that it will present at the LD Micro 10th Annual Main Event in Los Angeles, CA on December 5-7, 2017 (Press release, Navidea Biopharmaceuticals, NOV 21, 2017, View Source [SID1234522199]). Jed Latkin, Chief Financial Officer and Chief Operating Officer of Navidea, will be giving a presentation and meeting with investors throughout the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event:
LD Micro 10th Annual Main Event
Date:
Thursday, December 7th, 2017
Time:
9:30am PT (Pacific Time)
Location:
Luxe Sunset Boulevard Hotel, Los Angeles, CA

For investors attending the LD Micro Conference, please contact Navidea Investor Relations to schedule a meeting with Navidea management at [email protected] or [email protected].

The presentation will be webcast live and remain available for 90 days following the presentation. To access the webcast, please visit the Events tab of the Investor Relations section of the Navidea website at www.navidea.com.